• Please log in or register to access this feature.

ORIGINAL PAPER

You have free access to this content

Relationship of Cardiac Magnetic Resonance Imaging and Myocardial Biopsy in the Evaluation of Nonischemic Cardiomyopathy

  1. Jennifer A. Dickerson MD1,
  2. Subha V. Raman MD1,
  3. Peter M. Baker MD2,
  4. Carl V. Leier MD1

Article first published online: 11 SEP 2012

DOI: 10.1111/chf.12003

Issue

Congestive Heart Failure

Congestive Heart Failure

Volume 19, Issue 1, pages 29–38, January/February 2013

Additional Information

How to Cite

Dickerson, J. A., Raman, S. V., Baker, P. M. and Leier, C. V. (2013), Relationship of Cardiac Magnetic Resonance Imaging and Myocardial Biopsy in the Evaluation of Nonischemic Cardiomyopathy. Congestive Heart Failure, 19: 29–38. doi: 10.1111/chf.12003

Author Information

  1. 1

    From the Division of Cardiovascular Medicine, Davis Heart Lung Research Institute, The Ohio State University Medical Center, Columbus, OH;

  2. 2

    Department of Pathology, The Ohio State University, Nationwide Children’s Hospital, Columbus, OH

*Carl V. Leier, MD, Division of Cardiovascular Medicine, 473 West 12th Avenue, The Ohio State University, Columbus, OH 43210 E-mail: carl.leier@osumc.edu

Publication History

  1. Issue published online: 23 JAN 2013
  2. Article first published online: 11 SEP 2012
  3. Manuscript received: May 2, 2012; revised: July 23, 2012; accepted: July 26, 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (98K)

References

  • 1
    Zimmermann O, Grebe O, Merkle N, et al. Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail. 2006;8:162–166.
  • 2
    Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138–144.
  • 3
    Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215–223.
  • 4
    Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–1985.
  • 5
    Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52:1574–1580.
  • 6
    Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002.
  • 7
    McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59.
  • 8
    Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119:1977–2016.
  • 9
    Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol. 1989;14:915–920.
  • 10
    Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc. 1989;64:1235–1245.
  • 11
    Abdel-Aty H, Boye P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol. 2005;45:1815–1822.
  • 12
    Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250–1258.
  • 13
    Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol. 2006;48:2085–2093.
  • 14
    Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–2179.
  • 15
    Ptaszek LM, Price ET, Hu MY, Yang PC. Early diagnosis of hemochromatosis-related cardiomyopathy with magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7:689–692.
  • 16
    Syed IS, Glockner JF, Feng D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging. 2010;3:155–164.
  • 17
    Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51:1022–1030.
  • 18
    Maceira AM, Prasad SK, Hawkins PN, et al. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54–59.
  • 19
    Mekinian A, Lions C, Leleu X, et al. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. Am J Med. 2010;123:864–868.
  • 20
    Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2:1369–1377.
  • 21
    Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–193.
  • 22
    Fenoglio JJ Jr, Ursell PC, Kellogg CF, et al. Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med. 1983;308:12–18.
  • 23
    Angelini A, Crosato M, Boffa GM, et al. Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart. 2002;87:210–215.
  • 24
    Hosenpud JD, McAnulty JH, Niles NR. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. J Am Coll Cardiol. 1985;6:797–801.
  • 25
    Mason JW, Billingham ME, Ricci DR. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol. 1980;45:1037–1044.
  • 26
    Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology. 2008;246:401–409.
  • 27
    Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53:1475–1487.
  • 28
    De Cobelli F, Pieroni M, Esposito A, et al. Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol. 2006;47:1649–1654.
  • 29
    Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114:1581–1590.
  • 30
    Bozkurt B, Mann DL, Deswal A. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010;15:331–341.
  • 31
    Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30:1354–1359.
  • 32
    Andreoletti L, Leveque N, Boulagnon C, et al. Viral causes of human myocarditis. Arch Cardiovasc Dis. 2009;102:559–568.
  • 33
    Yilmaz A, Kindermann I, Kindermann M, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance. Circulation. 2010;122:900–909.
View Full Article (HTML) Get PDF (98K)